Usefulness of Selegiline for Smoking Cessation

NCT00129311 Phase 2 COMPLETED Results posted

Despite the widespread use of nicotine replacement therapies for the treatment of nicotine dependence, many smokers are still unable to quit smoking. The purpose of this study is to determine the safety and effectiveness of selegiline as an aid to help smokers quit smoking.

Details

Lead sponsor	Yale University
Phase	Phase 2
Status	COMPLETED
Enrolment	101
Start date	2004-07
Completion	2012-12

Conditions

• Tobacco Use Cessation

Interventions

• Selegiline
• Placebo

Primary outcomes

• 7 Day Point Prevalence of Cigarette Abstinence — 6-month follow up
• 7 Day Point Prevalence of Cigarette Abstinence — Week 8

Countries

United States